Share
Market Research Report

CANCER CHEMOTHERAPY ASSOCIATED NAUSEA AND VOMITING THERAPEUTICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By TypeAcute CINV · Delayed CINV · Anticipatory nausea and emesis and Breakthrough CINV/Refractory CINV
  • By Drug ClassDopamine Receptor Antagonists (Metoclopramide, Chlorpromazine, Prochlorperazine, Haloperidol, Droperidol and Others) · Serotonin (5-HT3) receptor Antagonists (Ondansetron, Granisetron, Palonosetron, Dolasetron and others) · Substance P/NK-1 Antagonists (Aprepitant, Fosaprepitant, Netupitant, and Others) · Corticosteroids (Dexamethasone and Methylprednisolone) and others
  • By Route of AdministrationOral · Parenteral and Transdermal Patch
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • Published In29 Apr 2026
  • Report CodeCMI5823
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033

Detailed Segmentation:

  • Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, Type (Revenue, USD Mn, 2021 - 2033)

    • Acute CINV
    • Delayed CINV
    • Anticipatory nausea and emesis
    • Breakthrough CINV/Refractory CINV
  • Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, Drug Class:

    • Dopamine Receptor Antagonists
      • Metoclopramide
      • Chlorpromazine
      • Prochlorperazine
      • Haloperidol
      • Droperidol
      • Others
    • Serotonin (5-HT3) receptor Antagonists
      • Ondansetron
      • Granisetron
      • Palonosetron
      • Dolasetron
      • Others
    • Substance P/NK-1 Antagonists
      • Aprepitant
      • Fosaprepitant
      • Netupitant
      • Others
    • Corticosteroids
      • Dexamethasone
      • Methylprednisolone
    • Others
  • Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Route of Administration (Revenue, USD Mn, 2021 - 2033)

    • Oral
    • Parenteral
    • Transdermal Patch
  • Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Cancer Chemotherapy Associated Nausea and Vomiting Therapeutics Market, By Region (Revenue, USD Mn, 2021 - 2033)

    • North America
      • By Type
        • Acute CINV
        • Delayed CINV
        • Anticipatory nausea and emesis
        • Breakthrough CINV/Refractory CINV
      • By Drug Class
        • Dopamine Receptor Antagonists
          • Metoclopramide
          • Chlorpromazine
          • Prochlorperazine
          • Haloperidol
          • Droperidol
          • Others
        • Serotonin (5-HT3) receptor Antagonists
          • Ondansetron
          • Granisetron
          • Palonosetron
          • Dolasetron
          • Others
        • Substance P/NK-1 Antagonists
          • Aprepitant
          • Fosaprepitant
          • Netupitant
          • Others
        • Corticosteroids
          • Dexamethasone
          • Methylprednisolone
        • Others
      • By Route of Administration
        • Oral
        • Parenteral
        • Transdermal Patch
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Type
        • Acute CINV
        • Delayed CINV
        • Anticipatory nausea and emesis
        • Breakthrough CINV/Refractory CINV
      • By Drug Class
        • Dopamine Receptor Antagonists
          • Metoclopramide
          • Chlorpromazine
          • Prochlorperazine
          • Haloperidol
          • Droperidol
          • Others
        • Serotonin (5-HT3) receptor Antagonists
          • Ondansetron
          • Granisetron
          • Palonosetron
          • Dolasetron
          • Others
        • Substance P/NK-1 Antagonists
          • Aprepitant
          • Fosaprepitant
          • Netupitant
          • Others
        • Corticosteroids
          • Dexamethasone
          • Methylprednisolone
        • Others
      • By Route of Administration
        • Oral
        • Parenteral
        • Transdermal Patch
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Type
        • Acute CINV
        • Delayed CINV
        • Anticipatory nausea and emesis
        • Breakthrough CINV/Refractory CINV
      • By Drug Class
        • Dopamine Receptor Antagonists
          • Metoclopramide
          • Chlorpromazine
          • Prochlorperazine
          • Haloperidol
          • Droperidol
          • Others
        • Serotonin (5-HT3) receptor Antagonists
          • Ondansetron
          • Granisetron
          • Palonosetron
          • Dolasetron
          • Others
        • Substance P/NK-1 Antagonists
          • Aprepitant
          • Fosaprepitant
          • Netupitant
          • Others
        • Corticosteroids
          • Dexamethasone
          • Methylprednisolone
        • Others
      • By Route of Administration
        • Oral
        • Parenteral
        • Transdermal Patch
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Type
        • Acute CINV
        • Delayed CINV
        • Anticipatory nausea and emesis
        • Breakthrough CINV/Refractory CINV
      • By Drug Class
        • Dopamine Receptor Antagonists
          • Metoclopramide
          • Chlorpromazine
          • Prochlorperazine
          • Haloperidol
          • Droperidol
          • Others
        • Serotonin (5-HT3) receptor Antagonists
          • Ondansetron
          • Granisetron
          • Palonosetron
          • Dolasetron
          • Others
        • Substance P/NK-1 Antagonists
          • Aprepitant
          • Fosaprepitant
          • Netupitant
          • Others
        • Corticosteroids
          • Dexamethasone
          • Methylprednisolone
        • Others
      • By Route of Administration
        • Oral
        • Parenteral
        • Transdermal Patch
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Type
        • Acute CINV
        • Delayed CINV
        • Anticipatory nausea and emesis
        • Breakthrough CINV/Refractory CINV
      • By Drug Class
        • Dopamine Receptor Antagonists
          • Metoclopramide
          • Chlorpromazine
          • Prochlorperazine
          • Haloperidol
          • Droperidol
          • Others
        • Serotonin (5-HT3) receptor Antagonists
          • Ondansetron
          • Granisetron
          • Palonosetron
          • Dolasetron
          • Others
        • Substance P/NK-1 Antagonists
          • Aprepitant
          • Fosaprepitant
          • Netupitant
          • Others
        • Corticosteroids
          • Dexamethasone
          • Methylprednisolone
        • Others
      • By Route of Administration
        • Oral
        • Parenteral
        • Transdermal Patch
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Type
        • Acute CINV
        • Delayed CINV
        • Anticipatory nausea and emesis
        • Breakthrough CINV/Refractory CINV
      • By Drug Class
        • Dopamine Receptor Antagonists
          • Metoclopramide
          • Chlorpromazine
          • Prochlorperazine
          • Haloperidol
          • Droperidol
          • Others
        • Serotonin (5-HT3) receptor Antagonists
          • Ondansetron
          • Granisetron
          • Palonosetron
          • Dolasetron
          • Others
        • Substance P/NK-1 Antagonists
          • Aprepitant
          • Fosaprepitant
          • Netupitant
          • Others
        • Corticosteroids
          • Dexamethasone
          • Methylprednisolone
        • Others
      • By Route of Administration
        • Oral
        • Parenteral
        • Transdermal Patch
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • Online Pharmacies
      • By Country/Regions
        • South Africa
        • Central Africa
        • North Africa